title: Pharmacogenetics of warfarin: challenges and opportunities.
abstract: Since the introduction in the 1950s, warfarin has become the commonly used oral anticoagulant for the prevention of thromboembolism in patients with deep vein thrombosis, atrial fibrillation or prosthetic heart valve replacement. Warfarin is highly efficacious; however, achieving the desired anticoagulation is difficult because of its narrow therapeutic window and highly variable dose response among individuals. Bleeding is often associated with overdose of warfarin. There is overwhelming evidence that an individual's warfarin maintenance is associated with clinical factors and genetic variations, most notably polymorphisms in cytochrome P450 2C9 and vitamin K epoxide reductase subunit 1. Numerous dose-prediction algorithms incorporating both genetic and clinical factors have been developed and tested clinically. However, results from major clinical trials are not available yet. This review aims to provide an overview of the field of warfarin which includes information about the drug, genetics of warfarin dose requirements, dosing algorithms developed and the challenges for the clinical implementation of warfarin pharmacogenetics.
authors: Laboratory for International Alliance, RIKEN Center for Genomic Medicine, Yokohama, Japan.
authors: Ming Ta Michael
authors: MT
authors: Lee
authors: Teri E
authors: TE
authors: Klein
mesh_terms: D000284:Administration, Oral; D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000517:prevention & control; D065729:Cytochrome P-450 CYP2C9; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D016032:Randomized Controlled Trials as Topic; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control; D064417:Vitamin K Epoxide Reductases / Q000235:genetics; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D064417:Vitamin K Epoxide Reductases
references: Thromb Haemost. 2004 Jan;91(1):87-94
references: 14691573
references: Thromb Haemost. 2004 Oct;92(4):797-802
references: 15467911
references: J Pharm Pharmacol. 1987 Jun;39(6):416-20
references: 2886597
references: Blood. 2008 Aug 15;112(4):1022-7
references: 18535201
references: N Engl J Med. 2009 Feb 19;360(8):753-64
references: 19228618
references: Trials. 2012 Dec 13;13:239
references: 23237631
references: Clin Pharmacol Ther. 1992 Apr;51(4):398-407
references: 1563209
references: Thromb Res. 2007;120(2):181-6
references: 17049586
references: Clin Pharmacol Ther. 2001 Aug;70(2):159-64
references: 11503010
references: Nature. 1972 May 5;237(5349):32-3
references: 4555434
references: Chest. 1995 Oct;108(4 Suppl):371S-379S
references: 7555190
references: Am J Clin Nutr. 1993 Aug;58(2):204-8
references: 8393269
references: Pharmacogenetics. 1996 Aug;6(4):341-9
references: 8873220
references: Eur J Clin Pharmacol. 2012 Mar;68(3):321-8
references: 21935704
references: Clin Pharmacol Ther. 2012 Dec;92(6):746-56
references: 23132553
references: J Biol Chem. 2004 Jun 11;279(24):25276-83
references: 15075329
references: Thromb Haemost. 2012 Jun;107(6):1083-91
references: 22534826
references: Clin Pharmacol Ther. 2008 Dec;84(6):722-8
references: 18754001
references: J Thromb Haemost. 2004 Dec;2(12):2118-32
references: 15613016
references: Pharmacogenomics. 2009 Aug;10(8):1243-55
references: 19663669
references: Blood. 2007 Sep 1;110(5):1511-5
references: 17387222
references: Pharmacol Ther. 1997;73(1):67-74
references: 9014207
references: Chest. 1995 Oct;108(4 Suppl):352S-359S
references: 7555188
references: Clin Ther. 2008 Sep;30(9):1726-36
references: 18840379
references: Pharmacogenomics J. 2005;5(4):262-70
references: 15883587
references: Alcohol Res Health. 1999;23(1):40-54
references: 10890797
references: J Thromb Haemost. 2010 May;8(5):1018-26
references: 20128861
references: Circulation. 2007 Nov 27;116(22):2563-70
references: 17989110
references: Br J Haematol. 2011 Aug;154(3):311-24
references: 21671894
references: Am J Med. 1993 Sep;95(3):315-28
references: 8368229
references: J Clin Invest. 1985 Nov;76(5):1879-84
references: 3932474
references: Genet Med. 2011 Jun;13(6):509-18
references: 21423021
references: Clin Pharmacol Ther. 2005 May;77(5):365-72
references: 15900282
references: Hum Mol Genet. 2010 Dec 1;19(23):4735-44
references: 20833655
references: Blood. 2011 Sep 15;118(11):3163-71
references: 21725053
references: Genet Test Mol Biomarkers. 2011 Nov;15(11):827-30
references: 21651319
references: Lancet. 1999 Feb 27;353(9154):717-9
references: 10073515
references: Clin Pharmacol Ther. 2004 Mar;75(3):204-12
references: 15001972
references: Am Heart J. 1992 Apr;123(4 Pt 2):1115-22
references: 1553881
references: Thromb Haemost. 2005 Apr;93(4):700-5
references: 15841315
references: Clin Pharmacol Ther. 2008 Jul;84(1):83-9
references: 18183038
references: J Am Coll Cardiol. 2010 Jun 22;55(25):2804-12
references: 20381283
references: J Biol Chem. 2002 Aug 9;277(32):28584-91
references: 12034728
references: Am J Hum Genet. 2008 Feb;82(2):495-500
references: 18252229
references: Clin Ther. 2012 Jul;34(7):1569-82
references: 22717419
references: J Am Coll Cardiol. 2011 Feb 1;57(5):612-8
references: 21272753
references: J Hum Genet. 2012 Oct;57(10):665-9
references: 22854539
references: Per Med. 2007 May 1;4(2):157-169
references: 19802360
references: Blood. 2012 Jan 19;119(3):861-7
references: 22130800
references: Nature. 2004 Feb 5;427(6974):541-4
references: 14765195
references: J Thromb Thrombolysis. 1994;1(1):17-25
references: 10603507
references: Clin Pharmacol Ther. 2011 Oct;90(4):625-9
references: 21900891
references: Blood. 2010 May 6;115(18):3827-34
references: 20203262
references: Thromb Haemost. 2000 Jun;83(6):849-52
references: 10896237
references: Nature. 2004 Feb 5;427(6974):537-41
references: 14765194
references: Mol Pharmacol. 2009 Jun;75(6):1337-46
references: 19297519
references: J Thromb Haemost. 2008 Oct;6(10):1655-62
references: 18662264
references: N Engl J Med. 2005 Jun 2;352(22):2285-93
references: 15930419
references: J Am Coll Cardiol. 2003 May 7;41(9):1633-52
references: 12742309
references: J Hum Genet. 2007;52(10):856-864
references: 17786385
references: Clin Pharmacol Ther. 2003 Mar;73(3):253-63
references: 12621390
references: Acta Neurol Scand. 1985 Jun;71(6):464-71
references: 4024857
references: Eur J Clin Pharmacol. 2009 Apr;65(4):365-75
references: 19031075
references: Circulation. 2012 Apr 24;125(16):1997-2005
references: 22431865
references: Biochemistry. 2001 Oct 2;40(39):11723-33
references: 11570873
references: J Thromb Haemost. 2007 Nov;5(11):2227-34
references: 17764537
references: Pharmacogenomics J. 2004;4(1):40-8
references: 14676821
references: J Hum Genet. 2011 Apr;56(4):290-5
references: 21326313
references: Clin Lab Haematol. 1995 Dec;17(4):339-45
references: 8697730
references: N Engl J Med. 2011 Nov 24;365(21):2002-12
references: 22111719
references: Clin Pharmacol Ther. 2008 Mar;83(3):460-70
references: 17851566
references: Hum Mol Genet. 2005 Jul 1;14(13):1745-51
references: 15888487
references: N Engl J Med. 2011 Sep 8;365(10):883-91
references: 21830957
references: Chem Res Toxicol. 1992 Jan-Feb;5(1):54-9
references: 1581537
references: Clin Pharmacol Ther. 2010 Apr;87(4):459-64
references: 20072124
references: PLoS Genet. 2009 Mar;5(3):e1000433
references: 19300499
references: BMC Med Genet. 2011 Jun 06;12:80
references: 21639946
references: Blood. 2012 Jan 19;119(3):868-73
references: 22010099
references: Ther Drug Monit. 2010 Jun;32(3):338-45
references: 20386359
references: Pharmacogenetics. 1995 Dec;5(6):389-92
references: 8747411
references: Pharmacogenomics J. 2003;3(4):202-14
references: 12931134
references: Blood. 2005 Nov 15;106(10):3673-4
references: 16267263
references: Blood. 2008 Apr 15;111(8):4106-12
references: 18250228
references: J Thromb Haemost. 2004 Aug;2(8):1490-1; reply 1492-4
references: 15304071
references: N Engl J Med. 2009 Sep 17;361(12):1139-51
references: 19717844
references: J Biol Chem. 1997 Nov 14;272(46):29068-75
references: 9360981
references: Semin Vasc Med. 2003 Aug;3(3):221-30
references: 15199454
references: CMAJ. 2007 Aug 14;177(4):369-71
references: 17698826
references: Am J Kidney Dis. 2010 Nov;56(5):823-31
references: 20709439
references: Pharmacogenetics. 1997 Feb;7(1):51-8
references: 9110362
references: J Clin Pathol. 1993 Apr;46(4):299-303
references: 8496384
references: Circulation. 2011 Jun 7;123(22):2562-70
references: 21606397
references: Blood. 2004 Apr 1;103(7):2630-5
references: 14656880
references: J Thromb Thrombolysis. 2006 Dec;22(3):191-7
references: 17111199
references: Pharmacogenomics. 2009 Dec;10(12):1905-13
references: 19958090
references: Br J Clin Pharmacol. 2008 Feb;65(2):260-4
references: 17995970
references: Chest. 2001 Jan;119(1 Suppl):8S-21S
references: 11157640